Dr Miles Congreve joins Heptares
This article was originally published in Scrip
Executive Summary
Heptares Therapeutics, a UK drug discovery company focused on the design and development of drugs based on G-protein-coupled receptors, has named Dr Miles Congrevehead of chemistry. He joins from Astex Therapeutics, where he was director of chemistry.